Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Oral Medicine · Oral Leukoplakia

Can an Oral Leukoplakia Biopsy Miss Cancer or Dysplasia?

At a Glance

Yes. Oral leukoplakia can contain mild and severe changes in different areas, so a small biopsy may miss cancer or severe dysplasia. If the patch looks suspicious, changes, or persists, doctors may recommend specialist review, repeat or multiple biopsies, removal, and long-term monitoring.

Yes. It is possible for an incisional biopsy (which removes only a small piece of tissue) to miss cancer or severe dysplasia in oral leukoplakia. Dysplasia refers to abnormal, precancerous cell changes; a biopsy might accurately show mild dysplasia or no dysplasia in the exact spot sampled, while missing a more severe area nearby [1].

If your biopsy results indicate no dysplasia or mild dysplasia, this can be reassuring if the lesion is small, uniform, and looks low-risk to your doctor. However, if the lesion is large, uneven, or highly suspicious, a single small biopsy might not tell the whole story [2]. In one study looking specifically at cases where the initial biopsy diagnosis did not match the final diagnosis after the whole lesion was removed, sampling error—meaning the biopsy was taken from a less severe part of the patch—accounted for 60% of those mismatches [3].

Why a Biopsy Might Underestimate Dysplasia

Oral leukoplakia lesions are often heterogeneous, meaning their cellular makeup is not the same across the entire patch. A single lesion can have areas of normal tissue, mild dysplasia, and severe dysplasia right next to one another.

Several factors contribute to a biopsy missing a more severe area:

  • Sampling Location: In large, uneven, or mixed red-and-white lesions, the most abnormal cells might be concentrated in one small spot. If that specific spot is not sampled, the results will underestimate the true severity of the disease [3].
  • Biopsy Depth: To accurately grade dysplasia or check for invasive cancer, a pathologist needs to see the full thickness of the oral mucosa (the mouth’s surface lining) and the underlying connective tissue. If a biopsy is too superficial or fragmented, it may fail to include enough tissue for an accurate diagnosis [4].
  • Multifocal Disease: Some patients have multiple patches of leukoplakia scattered throughout the mouth. Testing one patch does not tell you what is happening in the others, and cancer can be present in unbiopsied areas [5].

The Challenge of Proliferative Verrucous Leukoplakia (PVL)

Proliferative verrucous leukoplakia (PVL) is a specific, aggressive form of leukoplakia that is especially prone to sampling errors. PVL typically starts as flat white patches that slowly spread over time, eventually becoming thick, warty (verrucous), and involving multiple areas of the mouth [6].

A major challenge with PVL is that early biopsies often show only hyperkeratosis (thickening of the surface lining) without any signs of dysplasia [7]. While this looks benign under a microscope, it is not harmless if the lesion continues to spread. PVL carries a substantial risk of eventually transforming into oral cancer and is diagnosed by observing its progressive clinical pattern over time, not just from a single biopsy [8]. Because early biopsies can look benign, a single “normal” result does not mean you are in the clear if the patches continue to grow [6][7].

How Doctors Target the Most Concerning Areas

To reduce the risk of sampling error, specialists carefully examine the lesion to target the most suspicious areas.

  • Visual and Physical Clues: Doctors look for high-risk features within the leukoplakia, such as red patches (erythroplakia), ulcerations, nodules (lumps), firmness (induration), or areas that bleed easily [9].
  • Taking Multiple Samples: For large, heterogeneous, or multifocal lesions, taking multiple biopsies from different sites provides a much more accurate picture of the disease [3].
  • Advanced Imaging: In some specialist centers, doctors use narrow-band imaging (NBI) as an adjunct tool. NBI uses special light to highlight abnormal blood vessel patterns, which can help guide the doctor to the best spot to biopsy. However, NBI does not replace a physical tissue biopsy [10].

When is Reassessment or Removal Warranted?

Because of the risk of sampling error, a biopsy report of “benign” or “mild dysplasia” is not the end of your evaluation if your doctor remains concerned [2]. You should seek prompt specialist reassessment if:

  • The clinical picture doesn’t match the pathology: If your doctor strongly suspects a high-grade problem based on how the lesion looks and feels, but the biopsy comes back as mild or benign (clinicopathologic discordance), this should always prompt a second look or repeat biopsy [2][11].
  • The lesion changes: Contact your treating clinician promptly if the leukoplakia rapidly grows, becomes red, develops a rough texture, or if you develop a non-healing ulcer, persistent bleeding, increasing pain, or a lump [12].
  • The lesion persists: If a suspicious patch remains despite clinician-directed management of local trauma (like sharp teeth), it requires prompt evaluation [2]. (Note: Tobacco and alcohol are major risk factors that should be stopped, but eliminating them should not delay the biopsy of a suspicious lesion).

For some persistent or high-risk leukoplakias, the clinician may recommend complete surgical removal (excision). Excision reduces the chance of missing severe disease within that specific patch of tissue [5][13]. However, excision is just one individualized option. It is not always possible for large or multifocal lesions, and it does not guarantee that new lesions won’t form elsewhere. Whether a lesion is monitored, biopsied again, or completely removed, long-term surveillance is almost always needed [5].

Common questions in this guide

Can a small biopsy of oral leukoplakia miss cancer?
Yes. An incisional biopsy samples only part of a lesion, and the most abnormal area may be elsewhere in the patch. A result showing no abnormal precancerous change or only mild change may therefore underestimate the lesion when its appearance remains concerning.
What makes an oral leukoplakia biopsy underestimate the severity?
Leukoplakia can be uneven, with normal tissue, mild changes, and severe changes side by side. A sample taken from a less abnormal spot, taken too shallowly, or fragmented may not show the full picture. Multiple samples and adequate depth can improve assessment.
What should I do if my biopsy result does not match how the lesion looks?
Ask your clinician whether the result and the lesion are clinically consistent. If the patch is large, mixed red and white, growing, firm, ulcerated, or otherwise suspicious, prompt reassessment may include a repeat or multiple-site biopsy, review by an oral and maxillofacial pathologist, or excision.
Can a normal biopsy rule out cancer in proliferative verrucous leukoplakia?
No. Early proliferative verrucous leukoplakia may show only thickened surface tissue under the microscope even while the condition continues to spread. Because assessment depends on the lesion’s behavior over time as well as biopsy findings, ongoing specialist follow-up is important.
What changes in an oral leukoplakia patch need prompt medical review?
Contact your treating clinician promptly if the patch grows quickly, becomes red, thick or rough, bleeds, develops a non-healing ulcer, or causes increasing pain or a lump. A persistent suspicious patch also deserves reassessment even if an earlier biopsy was benign or showed only mild changes.
Does a mild or benign biopsy mean oral leukoplakia should not be removed?
Not necessarily. For a persistent or high-risk patch, complete surgical removal may reduce the chance of missing a more severe area in that specific lesion, but removal is not suitable for every large or multifocal patch and does not prevent new lesions elsewhere. Long-term surveillance is still usually needed.

Get notified when new evidence is published on oral mucosa leukoplakia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Diagnostic discrepancies in the surgical management of oral epithelial dysplasia - an analysis of concordance between incisional biopsy and definitive resection specimens.

    Maloney B, Jung MS, Byrne J, et al.

    Oral surgery, oral medicine, oral pathology and oral radiology 2026; (142(3)):362-374 doi:10.1016/j.oooo.2026.03.001.

    PMID: 42020233
  2. 2

    When Clinical Suspicion Outweighs a Negative Biopsy: Early Tongue Squamous Cell Carcinoma Diagnosed After Persistent Oral Leukoplakia.

    Reboredo P, Nogueira P, Boer N, et al.

    Cureus 2026; (18(8)):e114040 doi:10.7759/cureus.114040.

    PMID: 42701507
  3. 3

    The Diagnostic Accuracy of Incisional Biopsy in the Oral Cavity.

    Chen S, Forman M, Sadow PM, August M

    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2016; (74(5)):959-64.

    PMID: 26682520
  4. 4

    Histological features of differentiated dysplasia in the oral mucosa: a review of oral invasive squamous cell carcinoma cases diagnosed with benign or low-grade dysplasia on previous biopsies.

    Kim E, Chung M, Jeong HS, et al.

    Human pathology 2022; (126()):45-54 doi:10.1016/j.humpath.2022.05.010.

    PMID: 35597368
  5. 5

    Prevalence of Carcinomatous Foci in Oral Leukoplakia: A Clinicopathologic Study of 546 Indian Samples.

    Gopinath D, Thannikunnath BV, Neermunda SF

    Journal of clinical and diagnostic research : JCDR 2016; (10(8)):ZC78-83 doi:10.7860/JCDR/2016/16815.8305.

    PMID: 27656569
  6. 6

    A Scoping Review on Gaps in the Diagnostic Criteria for Proliferative Verrucous Leukoplakia: A Conceptual Proposal and Diagnostic Evidence-Based Criteria.

    González-Moles MÁ, Ramos-García P, Warnakulasuriya S

    Cancers 2021; (13(15)) doi:10.3390/cancers13153669.

    PMID: 34359571
  7. 7

    Malignant transformation of verrucous oral potentially malignant disorders at a tertiary referral centre: A retrospective cohort study.

    Platais C, Clark M, Hankinson P, et al.

    Oral oncology 2026; (180()):108040 doi:10.1016/j.oraloncology.2026.108040.

    PMID: 42247780
  8. 8

    Malignant transformation of oral proliferative verrucous leukoplakia: A systematic review and meta-analysis.

    Ramos-García P, González-Moles MÁ, Mello FW, et al.

    Oral diseases 2021; (27(8)):1896-1907 doi:10.1111/odi.13831.

    PMID: 34009718
  9. 9

    Clinical and Histologic Features Associated With Malignant Transformation of Oral Cavity Dysplasia Managed at a Single North American Institution.

    Tang JA, Amadio G, Ridge JA

    JAMA otolaryngology-- head & neck surgery 2022; (148(1)):28-34 doi:10.1001/jamaoto.2021.2755.

    PMID: 35024779
  10. 10

    Diagnostic Accuracy of High-Grade Intraepithelial Papillary Capillary Loops by Narrow Band Imaging for Early Detection of Oral Malignancy: A Cross-Sectional Clinicopathological Imaging Study.

    Ota A, Miyamoto I, Ohashi Y, et al.

    Cancers 2022; (14(10)) doi:10.3390/cancers14102415.

    PMID: 35626019
  11. 11

    Characterization of initial/early histologic features of proliferative leukoplakia and correlation with malignant transformation: a multicenter study.

    Alabdulaaly L, Villa A, Chen T, et al.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022; (35(8)):1034-1044 doi:10.1038/s41379-022-01021-x.

    PMID: 35184151
  12. 12

    Clinico-Pathological Assessment and Malignant Transformation in Patients with Oral Epithelial Dysplasia - A Follow-up Cohort Study.

    Yasothkumar D, Ramani P, Ramasubramanian A

    Head and neck pathology 2025; (19(1)):96 doi:10.1007/s12105-025-01833-8.

    PMID: 40758174
  13. 13

    Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study.

    Chaturvedi AK, Udaltsova N, Engels EA, et al.

    Journal of the National Cancer Institute 2020; (112(10)):1047-1054 doi:10.1093/jnci/djz238.

    PMID: 31860085

This page is for informational purposes only and does not constitute medical advice. Your dentist, oral medicine specialist, or oral and maxillofacial pathologist should interpret your biopsy and guide follow-up for your specific lesion.